On the HCPLive Hepatitis C page, resources on the topics of medical news and expert insight into HCV can be found. Content includes articles, interviews, videos, podcasts, and breaking news on hepatitis C virus research, treatment, and drug development.
July 3rd 2024
This June 2024 month in review highlights hepatic pipeline developments, new MASH therapeutics on the road to FDA approval, and the latest installment of Qazi Corner.
Hepatitis C: Bronx Program Keeps Former Prison Inmates in Treatment
Prisoners who are able to get hepatitis C antivirals while they are still incarcerated can be lost to treatment when they are freed. A community linkage program in the Bronx, NY is having success keeping the patients on their drug regimens.
Tennessee Prison Officials Request Millions to Fight Hepatitis C
After a newspaper report found that less than 10 of Tennessee's thousands of HCV-positive prisoners were receiving treatment, two inmates sued the state. Now, prison officials are seeking a bit more help in battling the disease.
Hepatitis C Treatments Increasingly Available in Developing World, but Still Quite Costly in the US
October 31st 2016New hepatitis C treatments made accessible through competition and other access strategies have been given to over one million patients in as many as 13 low-and middle-income countries, according to a new report from the World Health Organization (WHO).
Restricted Reimbursement for DAAs Hinders Progress Towards Global Hepatitis C Eradication Goal
Although DAAs achieve sustained virologic response rates above 90%, they are expensive in both Canada and the US. A recent Canadian study examined the limitations hepatitis C patients there face in receiving reimbursement for their treatment.
Hepatitis C Virus Core Antigen Testing: What We Can Learn from the Protease Inhibitors
Measuring the hepatitis C virus (HCV) antigen in patients who are receiving protease inhibitors (PI) could provide an alternative to monitoring treatment response, according to a recent study.
Hep C Treatment: Why Aren't State Prisoners Getting It
Though under lock and key, state prisoners are considered "hard to reach" when it comes to getting them into treatment for hepatitis C. A health Affairs study looked at how states vary in attitudes, practices, and spending.
Pre-Exposure Treatment for Hepatitis C?
The concept of pre-exposure prophylaxis to prevent HIV infection is well established. In an editorial in Hepatology, and Australian researcher proposes extending the concept to people at high risk for getting hepatitis C: HIV-infected men who have sex with men.
Genetic Difference May Affect Drug Response in Hepatitis C
A genetic various appears to play a role in which patients are cured of hepatitis C infection, according to researchers who looked at patients treated with interferon plus ribavirin. The next question is whether that difference might play a role in response to direct-acting antivirals as well.